Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of September 2025. The report specifically details a transaction in the company's own shares executed under its share buyback programme.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity.
- Shares Purchased: 1,996,340 ordinary shares
- Purchase Date: September 29, 2025
- Price Range: 328.70p (Low) to 331.60p (High)
- Volume Weighted Average Price: 330.3042p
- Treasury Shares Held: 42,900,783 (post-settlement)
- Voting Shares Outstanding: 8,909,452,865
Material Changes
This transaction represents the second tranche of a share buyback programme announced on July 31, 2025. The purchase reduced the number of shares with voting rights and increased the company's treasury share holdings.
Guidance, Outlook, and Risks
The filing contains no financial guidance, management commentary on future performance, or discussion of risks and contingencies. It is a regulatory disclosure of a completed share transaction.
Key Facts for Investor Verification
- Verify the total number of shares purchased under the full buyback programme announced in July 2025.
- Confirm the remaining authorization limit for the current buyback programme.
- Review the full trade breakdown available via the London Stock Exchange link provided in the filing.
- Check subsequent filings for updates on the company's overall capital allocation strategy.